Treatment of Moderate to Severe Plaque Psoriasis

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
To assess the efficacy and safety of TQH3906 in subjects with moderate to severe plaque psoriasis, as well as the PK and PD characteristics of multiple doses
Epistemonikos ID: 813ac0c2a71ff19358dfba3d6802505c9d8a81e7
First added on: Sep 01, 2024